[HTML][HTML] Third-generation tyrosine kinase inhibitors targeting epidermal growth factor receptor mutations in non-small cell lung cancer

TA Barnes, GM O'Kane, MD Vincent… - Frontiers in oncology, 2017 - frontiersin.org
Sensitizing mutations in the epidermal growth factor receptor (EGFR) predict response to
EGFR tyrosine kinase inhibitors (TKIs) and both first-and second-generation TKIs are …

[PDF][PDF] Third-Generation Tyrosine Kinase inhibitors Targeting epidermal Growth Factor Receptor Mutations in non-Small Cell Lung Cancer

TA Barnes, GM O'Kane, MD Vincent… - Frontiers in …, 2017 - academia.edu
Sensitizing mutations in the epidermal growth factor receptor (EGFR) predict response to
EGFR tyrosine kinase inhibitors (TKIs) and both first-and second-generation TKIs are …

[引用][C] Third-Generation Tyrosine Kinase Inhibitors Targeting Epidermal Growth Factor Receptor Mutations in Non-Small Cell Lung Cancer

TA Barnes, GM O'Kane, MD Vincent, NB Leighl - Frontiers in Oncology, 2017 - cir.nii.ac.jp
Third-Generation Tyrosine Kinase Inhibitors Targeting Epidermal Growth Factor Receptor
Mutations in Non-Small Cell Lung Cancer | CiNii Research CiNii 国立情報学研究所 学術情報 …

Third-Generation Tyrosine Kinase Inhibitors Targeting Epidermal Growth Factor Receptor Mutations in Non-Small Cell Lung Cancer

TA Barnes, GM O'Kane, MD Vincent… - Frontiers in …, 2017 - pubmed.ncbi.nlm.nih.gov
Sensitizing mutations in the epidermal growth factor receptor (EGFR) predict response to
EGFR tyrosine kinase inhibitors (TKIs) and both first-and second-generation TKIs are …

Third-Generation Tyrosine Kinase Inhibitors Targeting Epidermal Growth Factor Receptor Mutations in Non-Small Cell Lung Cancer.

TA Barnes, GM O'Kane, MD Vincent… - Frontiers in …, 2017 - europepmc.org
Sensitizing mutations in the epidermal growth factor receptor (EGFR) predict response to
EGFR tyrosine kinase inhibitors (TKIs) and both first-and second-generation TKIs are …

[HTML][HTML] Third-Generation Tyrosine Kinase Inhibitors Targeting Epidermal Growth Factor Receptor Mutations in Non-Small Cell Lung Cancer

TA Barnes, GM O'Kane, MD Vincent… - Frontiers in …, 2017 - ncbi.nlm.nih.gov
Sensitizing mutations in the epidermal growth factor receptor (EGFR) predict response to
EGFR tyrosine kinase inhibitors (TKIs) and both first-and second-generation TKIs are …